The engine of Australia’s vibrant life sciences sector continues to accelerate, driven by groundbreaking innovation and a robust investment landscape. For both ambitious companies seeking capital and astute investors looking for high-potential ventures, applications are now officially open for AusBiotech Invest 2025 – your essential connection point in October.
The Australian biotech sector is experiencing momentum. In Q1 2025, early-stage venture capital median deal sizes for Pre-Seed and Seed rounds increased significantly, signalling renewed investor confidence in foundational innovations. This positive trend underscores a prime environment for strategic investment. Globally, the biotech market is projected to reach USD 546 billion by 2025, emphasising the vast opportunities.
For organisations seeking to pitch, AusBiotech Invest offers an unparalleled platform. Present your groundbreaking technologies directly to a concentrated audience of domestic and international VCs, angel investors, and corporate partners. This is your chance to showcase your unique value proposition, gain critical exposure, and engage in crucial one-to-one investment partnering. The structured environment is designed for maximum efficiency, helping you fast-track your path to securing the capital needed for development and commercialisation. Don’t miss this opportunity to connect with decision-makers who can transform your vision into reality.
For investors, AusBiotech Invest provides exclusive access to a curated pipeline of Australia’s most promising biotech ventures. Discover pioneering research, assess innovative business models, and identify strategic co-investment opportunities. Benefit from expert insights on market trends and dedicated networking that streamlines your deal sourcing.
The time to secure your place at Australia’s flagship life sciences investment event is now.
How to be part of AusBiotech Invest 2025
Pitching Companies: Apply to Pitch by September 7, 2025 here.
Investors: Apply Now to secure your access AusBiotech Invest 2025.
